Τετάρτη 7 Δεκεμβρίου 2016

Pancytopenia associated with levetiracetam in an epileptic woman

Haematological toxicity due to antiepileptic drugs is uncommon, but the increased risk of aplastic anaemia has been reported. Few case reports have been published regarding pancytopenia associated with levetiracetam treatment, and its intrinsic pathogenesis is still unknown. We describe the case of a woman aged 77 years who presented with abdominal pain and loss of appetite. She had been taking valproic acid, due to a previous episode of epileptic seizures, and presented with drowsiness and dizziness. Valproate was discontinued and therapy with levetiracetam was initiated. 2 days later, we observed severe anaemia, leucopenia and thrombocytopenia, which were attributed to levetiracetam. Although she recovered soon after the treatment was discontinued, it took 2 weeks for cell counts to return to normal.



http://ift.tt/2gkbNZB

Spontaneous aneurysmal subarachnoid haemorrhage in a child with multiply recurrent posterior fossa juvenile pilocytic astrocytoma

Description

A 9-year-old boy with a history of posterior fossa juvenile pilocytic astrocytoma presented to the emergency room for lethargy and worsening headache. Three years earlier, he underwent near total resection of the tumour. Owing to the progressive disease, he had a second resection and underwent conformal radiation therapy, totalling 5040 cGy. In the following 2 years, he reported of severe headaches. Multiple brain MRIs with and without contrast and head CTs without contrast did not reveal disease recurrence or significant abnormality. On the day of presentation, the child again reported of a severe headache and was brought to the emergency department (ED). In the ED, he rapidly decompensated. Neurological examination showed a large and non-reactive right pupil. CT of the head revealed a spontaneous fresh haemorrhage in the right cerebellum. CT angiography showed an abnormal tangle of vessels off the right posterior–inferior cerebellar artery (figure 1A–C). Neurosurgical...



http://ift.tt/2h2IZD7

Paget Schroetter syndrome imaged in multiple modalities and successfully treated with pharmacomechanical thrombectomy

Description

A young man in his early 30s presented with a 3-day history of left upper arm swelling and erythema (figure 1). He had no significant medical history. Of note he had a strong family history of deep venous thrombosis (DVT) with both parents having had lower limb DVTs. D-dimers were elevated, and the remaining laboratory investigations were within normal limits.

Figure 1

Erythematous, oedematous left upper limb.

An upper limb Doppler ultrasound scan showed occlusive thrombus in the left subclavian vein (figure 2). A CT venogram further delineated the extent of the thrombus confirming the diagnosis of Paget Schroetter syndrome (figures 3 and 4). Subsequently, a conventional venogram was performed in conjunction with a therapeutic pharmacomechanical thrombectomy, which successfully restored flow in the left subclavian vein (figures 5 and 6).

...

http://ift.tt/2gkbJcj

Cerebral tuberculomas in a patient with hairy cell leukaemia treated with cladribine

A 67-year-old man was treated with cladribine for hairy cell leukaemia. A few weeks later, he presented with persistent headaches, intermittent hypoesthesia of the right upper limb and language impairment. Brain CT scan showed 3 contrast-enhancing lesions. MRI revealed infracentimetric nodular lesions with restricted diffusion. One of the lesions was surgically removed and tested positive for acid-fast bacilli. Moreover, Mycobacterium tuberculosis was confirmed by PCR. Antituberculous drugs were prescribed for 12 months, with complete resolution of neurological deficits. This case highlights the risk of mycobacterial infections associated with both hairy cell leukaemia and cladribine use, and the importance of screening and treatment of latent forms of tuberculosis in patients undergoing treatment with immunosuppressive drugs.



http://ift.tt/2h2KwJx

Issue Information



from Cancer via ola Kala on Inoreader http://ift.tt/2h2As3d
via IFTTT

Issue Information



http://ift.tt/2h2As3d

Comparison of prostate positioning guided by three-dimensional transperineal ultrasound and cone beam CT

Abstract

Objective

The accuracy of a transperineal three-dimensional ultrasound system (3DUS) was assessed for prostate positioning and compared to fiducial- and bone-based positioning in kV cone beam computed tomography (CBCT) during definitive radiotherapy of prostate cancer.

Methods

Each of the 7 patients had three fiducial markers implanted into the prostate before treatment. Prostate positioning was simultaneously measured by 3DUS and CBCT before each fraction. In total, 177 pairs of 3DUS and CBCT scans were collected. Bone-match and seed-match were performed for each CBCT. Using seed-match as a reference, the accuracy of 3DUS and bone-match was evaluated. Systematic and random errors as well as optimal setup margins were calculated for 3DUS and bone-match.

Results

The discrepancy between 3DUS and seed-match in CBCT (average ± standard deviation) was 0.0 ± 1.7 mm laterally, 0.2 ± 2.0 mm longitudinally, and 0.3 ± 1.7 mm vertically. Using seed-match as a reference, systematic errors for 3DUS were 1.2 mm, 1.1 mm, and 0.9 mm; and random errors were 1.4 mm, 1.8 mm, and 1.6 mm, on lateral, longitudinal, and vertical axes, respectively. By analogy, the difference of bone-match to seed-match was 0.1 ± 1.1 mm laterally, 1.3 ± 3.8 mm longitudinally, and 1.3 ± 4.5 mm vertically. Systematic errors were 0.5 mm, 2.2 mm, and 2.6 mm; and random errors were 1.0 mm, 3.1 mm, and 3.9 mm on lateral, longitudinal, and vertical axes, respectively. The accuracy of 3DUS was significantly higher than that of bone-match on longitudinal and vertical axes, but not on the lateral axis.

Conclusion

Image-guided radiotherapy of prostate cancer based on transperineal 3DUS was feasible, with overall small discrepancy to seed-match in CBCT in this retrospective study. Compared to bone-match, transperineal 3DUS achieved higher accuracy on longitudinal and vertical axes.



http://ift.tt/2hi9gwG

Stereotactic radiotherapy of vestibular schwannoma

Abstract

Objective

The aim of this publication is to present long-term data on functional outcomes and tumor control in a cohort of 107 patients treated with stereotactic radiotherapy (RT) for vestibular schwannoma.

Patients and methods

Included were 107 patients with vestibular schwannoma (primary or recurrent following resection) treated with stereotactic RT (either fractioned or single-dose radiosurgery) between October 2002 and December 2013. Local control and functional outcomes were determined. Analysis of hearing preservation was limited to a subgroup of patients with complete audiometric data collected before treatment and during follow-up. Vestibular function test (FVT) results could be analyzed in a subset of patients and were compared to patient-reported dizziness.

Results

After a mean follow-up of 46.3 months, actuarial local control for the whole cohort was 100% after 2, 97.6% after 5, and 94.1% after 10 years. In patients with primary RT, serviceable hearing was preserved in 72%. Predictors for preservation of serviceable hearing in multivariate analysis were time of follow-up (odds ratio, OR = 0.93 per month; p = 0.021) and pre-RT tumor size (Koos stage I–IIa vs. IIb–IV; OR = 0.15; p = 0.031). Worsening of FVT results was recorded in 17.6% (N = 3). Profound discrepancy of patient-reported dizziness and FVT results was observed after RT. In patients with primary RT, worsening of facial nerve function occurred in 1.7% (N = 1).

Conclusion

Stereotactic RT of vestibular schwannoma provides good functional outcomes and high control rates. Dependence of hearing preservation on time of follow-up and initial tumor stage has to be considered.



http://ift.tt/2gTcNEC

Understanding sarcomas and other rare tumors: an interview with Robin L Jones

Future Oncology Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/2h2tTgJ
via IFTTT

Fertility preservation before an ABVD protocol: no new evidence to support changing the recommendations

Future Oncology Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/2heyUGG
via IFTTT

Abscopal Regression Following SABR for Non-Small-Cell-Lung Cancer: a Case Report.

Abscopal Regression Following SABR for Non-Small-Cell-Lung Cancer: a Case Report.

Cancer Biol Ther. 2016 Dec 06;:0

Authors: Cong Y, Shen G, Wu S, Hao R

Abstract
Out-of-field tumor response, which is also called abscopal effect, bystander effect, or non-target effect, can be regarded as localized irradiation induced systemic antitumorigenic effects, indicating shrinkage of a tumor distant from the irradiated site. Although abscopal effect has been documented in several tumor types, it is a very rare phenomenon which is clinically reported in non-small-cell-lung carcinoma (NSCLC). Herein, we represent a rare case of patient with NSCLC with two lesions in the upper lobe of left lung who, after receiving stereotactic ablative radiation therapy (SABR) to one of the tumors, had an apparent spontaneous regression of the other mass in the lung, suggestive of a radiation-induced abscopal effect.

PMID: 27922336 [PubMed - as supplied by publisher]



http://ift.tt/2gT4A3n

"Anticancer Res"[jour]; +68 new citations

68 new pubmed citations were retrieved for your search. Click on the search hyperlink below to display the complete search results:

"Anticancer Res"[jour]

These pubmed results were generated on 2016/12/07

PubMed comprises more than 24 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.



from Cancer via ola Kala on Inoreader http://ift.tt/2hi26IC
via IFTTT

Abscopal Regression Following SABR for Non-Small-Cell-Lung Cancer: a Case Report.

Abscopal Regression Following SABR for Non-Small-Cell-Lung Cancer: a Case Report.

Cancer Biol Ther. 2016 Dec 06;:0

Authors: Cong Y, Shen G, Wu S, Hao R

Abstract
Out-of-field tumor response, which is also called abscopal effect, bystander effect, or non-target effect, can be regarded as localized irradiation induced systemic antitumorigenic effects, indicating shrinkage of a tumor distant from the irradiated site. Although abscopal effect has been documented in several tumor types, it is a very rare phenomenon which is clinically reported in non-small-cell-lung carcinoma (NSCLC). Herein, we represent a rare case of patient with NSCLC with two lesions in the upper lobe of left lung who, after receiving stereotactic ablative radiation therapy (SABR) to one of the tumors, had an apparent spontaneous regression of the other mass in the lung, suggestive of a radiation-induced abscopal effect.

PMID: 27922336 [PubMed - as supplied by publisher]



from Cancer via ola Kala on Inoreader http://ift.tt/2gT4A3n
via IFTTT

Abscopal Regression Following SABR for Non-Small-Cell-Lung Cancer: a Case Report.

Abscopal Regression Following SABR for Non-Small-Cell-Lung Cancer: a Case Report.

Cancer Biol Ther. 2016 Dec 06;:0

Authors: Cong Y, Shen G, Wu S, Hao R

Abstract
Out-of-field tumor response, which is also called abscopal effect, bystander effect, or non-target effect, can be regarded as localized irradiation induced systemic antitumorigenic effects, indicating shrinkage of a tumor distant from the irradiated site. Although abscopal effect has been documented in several tumor types, it is a very rare phenomenon which is clinically reported in non-small-cell-lung carcinoma (NSCLC). Herein, we represent a rare case of patient with NSCLC with two lesions in the upper lobe of left lung who, after receiving stereotactic ablative radiation therapy (SABR) to one of the tumors, had an apparent spontaneous regression of the other mass in the lung, suggestive of a radiation-induced abscopal effect.

PMID: 27922336 [PubMed - as supplied by publisher]



from Cancer via ola Kala on Inoreader http://ift.tt/2gT4A3n
via IFTTT

Understanding sarcomas and other rare tumors: an interview with Robin L Jones

Future Oncology Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/2h2tTgJ
via IFTTT

Understanding sarcomas and other rare tumors: an interview with Robin L Jones

Future Oncology Ahead of Print.


http://ift.tt/2h2tTgJ

Abscopal Regression Following SABR for Non-Small-Cell-Lung Cancer: a Case Report.

Abscopal Regression Following SABR for Non-Small-Cell-Lung Cancer: a Case Report.

Cancer Biol Ther. 2016 Dec 06;:0

Authors: Cong Y, Shen G, Wu S, Hao R

Abstract
Out-of-field tumor response, which is also called abscopal effect, bystander effect, or non-target effect, can be regarded as localized irradiation induced systemic antitumorigenic effects, indicating shrinkage of a tumor distant from the irradiated site. Although abscopal effect has been documented in several tumor types, it is a very rare phenomenon which is clinically reported in non-small-cell-lung carcinoma (NSCLC). Herein, we represent a rare case of patient with NSCLC with two lesions in the upper lobe of left lung who, after receiving stereotactic ablative radiation therapy (SABR) to one of the tumors, had an apparent spontaneous regression of the other mass in the lung, suggestive of a radiation-induced abscopal effect.

PMID: 27922336 [PubMed - as supplied by publisher]



from Cancer via ola Kala on Inoreader http://ift.tt/2gT4A3n
via IFTTT

Silencing of miR-1247 by DNA methylation promoted non-small-cell lung cancer cell invasion and migration by effects of STMN1

88x31.png



http://ift.tt/2gSPCu1

Erratum to: Baumann BC, Bosch WR, Bahl A, et al. Development and validation of consensus contouring guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy. Int J Radiat Oncol Biol Phys 2016;96:78-86.

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5





http://ift.tt/2gSuq7g

Early-Stage Lung Cancer, Surgery, and Stereotactic Body Radiation Therapy: Quality of Life

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): Gregory M.M. Videtic




http://ift.tt/2gSpWOl

Issue Highlights

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5





http://ift.tt/2hhwgfa

Transformative Technologies: The Crookes, Coolidge, and Cascade Tubes

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): Jesse N. Aronowitz




http://ift.tt/2hhzsr2

In Reply to Samaratunga et al

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): Anthony Zietman, Joseph Smith, Eric Klein, Michael Droller, Prokar Dasgupta, James Catto




http://ift.tt/2gSmTFx

N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): P.D. Brown, K.V. Ballman, J. Cerhan, S.K. Anderson, X.W. Carrero, A.C. Whitton, J. Greenspoon, I.F. Parney, N.N. Laack, J.B. Ashman, J.P. Bahary, C.G. Hadjipanayis, J.J. Urbanic, F.G. Barker, E. Farace, D. Khuntia, C. Giannini, J.C. Buckner, E. Galanis, D. Roberge




http://ift.tt/2hhzHSZ

Results of COG ACNS0331: A Phase III Trial of Involved-Field Radiotherapy (IFRT) and Low Dose Craniospinal Irradiation (LD-CSI) with Chemotherapy in Average-Risk Medulloblastoma: A Report from the Children's Oncology Group

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): J.M. Michalski, A. Janss, G. Vezina, A. Gajjar, I. Pollack, T.E. Merchant, T.J. FitzGerald, T. Booth, N.J. Tarbell, Y. Li, C.A. Billups, S.M. Perkins, R.D. Timmerman, J.M. Cherlow, R. Packer




http://ift.tt/2gSjpDb

A Phase III, Randomized Double-Blind Study of Doxepin Rinse versus Magic Mouthwash versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy with or without Chemotherapy (Alliance A221304)

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): R.C. Miller, J. Le-Rademacher, T.T.W. Sio, J.L. Leenstra, G.P. Rine, A. Curtis, A.K. Singh, J.A. Martenson, R.J. Novotny, A.D. Tan, P. Reiter, C.L. Loprinzi




http://ift.tt/2hhzq2o

Treatment with 6 Cycles of CVP or R-CVP after Involved Field Radiation Therapy (IFRT) Significantly Improves Progression-free Survival Compared to IFRT alone in Stage I-II Low Grade Follicular Lymphoma: Results of an International Randomized Trial

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): M.P. MacManus, R. Fisher, D. Roos, P. O'Brien, A.M.J. Macann, D. Christie, R.W. Tsang, S.R. Davis, D.J. Joseph, B. McClure, J. Seymour




http://ift.tt/2gSnuHx

In Reply to Fodor and Di Muzio

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): Lionel Perrier, Magali Morelle, Sophie Dussart, Philippe Giraud




http://ift.tt/2hhpw0H

Extreme Hypofractionation versus Conventionally Fractionated Radiotherapy for Intermediate Risk Prostate Cancer: Early Toxicity Results from the Scandinavian Randomized Phase III Trial “HYPO-RT-PC”

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): A. Widmark, A. Gunnlaugsson, L. Beckman, C. Thellenberg-Karlsson, M. Hoyer, M. Lagerlund, P. Fransson, J. Kindblom, C. Ginman, B. Johansson, M. Seke, K. Björnlinger, E. Kjellén, L. Franzen, P. Nilsson




http://ift.tt/2gSvbxd

In Reply to Leung

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): John P. Christodouleas, Libni J. Eapen, Brian C. Baumann




http://ift.tt/2hhptSz

Continued Benefit to Rectal Separation for Prostate RT: Final Results of a Phase III Trial

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): D.A. Hamstra, N.F. Mariados, D.K. Shah, S.M. Kurtzman, J.E. Sylvester, S.H. Zimberg, R.S. Hudes, L. Karsh, M.D. Logsdon, D.C. Beyer, M. Kos, R.A. Hsi, K. Forsythe, E.M. Soffen, P.M. Francke, H. Zhang, T.L. DeWeese, R.J. Ellis, C.A. Mantz, W.R. Bosch, J.M. Michalski




http://ift.tt/2gSoyeg

Low-Risk Meningioma: Initial Outcomes from NRG Oncology/RTOG 0539

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): L. Rogers, P. Zhang, M.A. Vogelbaum, A. Perry, L. Ashby, J. Modi, A. Alleman, J. Galvin, E. Youssef, J.A. Bovi, P.K. Sneed, W. McMillan, J.F. de Groot, D.C. Shrieve, Y. Chen, H.K.G. Shu, A. Chakravarti, M.P. Mehta




http://ift.tt/2hhApj2

Final Analysis of a Randomized Phase III Trial of Accelerated versus Conventional Fractionation Radiotherapy for Glottic Cancer of T1-2N0M0 (JCOG0701)

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): T. Kodaira, Y. Kagami, T. Shibata, N. Shikama, M. Hiraoka, Y. Nishimura, S. Ishikura, K. Nakamura, Y. Saito, Y. Matsumoto, K. Konishi, Y. Ito, T. Akimoto, K. Nakata, T. Toshiyasu, K. Nakagawa, Y. Nagata, T. Nishimura, T. Uno, M. Kataoka




http://ift.tt/2gSrcRo

A Multicenter Phase II Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): W.I. Jang, M.S. Kim, Y.S. Seo, J.K. Kang, E.K. Paik, C.W. Choi, A.R. Chang, Y.H. Park, E.S. Kim, S. Jo, W. Kim, S.H. Bae, H.J. Park




http://ift.tt/2hhnwFM

NRG Oncology/RTOG 1014: 3 Year Efficacy Report From a Phase II Study of Repeat Breast Preserving Surgery and 3D Conformal Partial Breast Re-Irradiation (PBrI) for In-Breast Recurrence

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): D.W. Arthur, J. Moughan, H.M. Kuerer, B.G. Haffty, L.W. Cuttino, D.A. Todor, N.L. Simone, S.B. Hayes, W.A. Woodward, B. McCormick, R.J. Cohen, W.M. Sahijdak, D.J. Canaday, D.R. Brown, A.D. Currey, C.M. Fisher, R. Jagsi, J.R. White




http://ift.tt/2gSjoiB

The KRAS-variant is a Biomarker of Cetuximab Response and Altered Immunity in Head and Neck Cancer: NRG Oncology/RTOG 0522

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): J.B. Weidhaas, J. Harris, D. Schaue, A.M. Chen, R.K. Chin, R. Axelrod, A.K. El-Naggar, A.K. Singh, T.J. Galloway, D. Raben, D. Wang, C.L. Matthiesen, V. Avizonis, R. Manon, O. Yumen, P.F. Nguyen-Tan, A. Trotti, H.D. Skinner, Q. Zhang, J. Sayre, R.L. Ferris, D. Sidransky, C. Chung




http://ift.tt/2hhwC5q

Shaping the Immune Landscape in Irradiated Breast Cancer Patients with Systemic TGF-β Blockade

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): D. Schaue, M. Xie, J. Ratikan, E. Micewicz, L. Hwang, K. Faull, J. Sayre, P. Lee, J. Glaspy, S. Demaria, S. Formenti, W.H. McBride




http://ift.tt/2gSiG4Y

Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial

1-s2.0-S0360301616X00144-cov150h.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): Anne-Marie Charpentier, Debra L. Friedman, Suzanne Wolden, Cindy Schwartz, Bethany Gill, Jenna Sykes, Alisha Albert-Green, Kara M. Kelly, Louis S. Constine, David C. Hodgson
PurposeTo evaluate whether clinical risk factors could further distinguish children with intermediate-risk Hodgkin lymphoma (HL) with rapid early and complete anatomic response (RER/CR) who benefit significantly from involved-field RT (IFRT) from those who do not, and thereby aid refinement of treatment selection.Methods and MaterialsChildren with intermediate-risk HL treated on the Children's Oncology Group AHOD 0031 trial who achieved RER/CR with 4 cycles of chemotherapy, and who were randomized to 21-Gy IFRT or no additional therapy (n=716) were the subject of this study. Recursive partitioning analysis was used to identify factors associated with clinically and statistically significant improvement in event-free survival (EFS) after randomization to IFRT. Bootstrap sampling was used to evaluate the robustness of the findings.ResultAlthough most RER/CR patients did not benefit significantly from IFRT, those with a combination of anemia and bulky limited-stage disease (n=190) had significantly better 4-year EFS with the addition of IFRT (89.3% vs 77.9% without IFRT; P=.019); this benefit was consistently reproduced in bootstrap analyses and after adjusting for other prognostic factors.ConclusionAlthough most patients achieving RER/CR had favorable outcomes with 4 cycles of chemotherapy alone, those children with initial bulky stage I/II disease and anemia had significantly better EFS with the addition of IFRT as part of combined-modality therapy. Further work evaluating the interaction of clinical and biologic factors and imaging response is needed to further optimize and refine treatment selection.



http://ift.tt/2hhpg1T

NRG Oncology/RTOG 1014: 3 Year Efficacy Report From a Phase II Study of Repeat Breast Preserving Surgery and 3D Conformal Partial Breast Re-Irradiation (PBrI) for In-Breast Recurrence

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): D.W. Arthur, J. Moughan, H.M. Kuerer, B.G. Haffty, L.W. Cuttino, D.A. Todor, N.L. Simone, S.B. Hayes, W.A. Woodward, B. McCormick, R.J. Cohen, W.M. Sahijdak, D.J. Canaday, D.R. Brown, A.D. Currey, C.M. Fisher, R. Jagsi, J.R. White




from Cancer via ola Kala on Inoreader http://ift.tt/2gSjoiB
via IFTTT

The KRAS-variant is a Biomarker of Cetuximab Response and Altered Immunity in Head and Neck Cancer: NRG Oncology/RTOG 0522

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): J.B. Weidhaas, J. Harris, D. Schaue, A.M. Chen, R.K. Chin, R. Axelrod, A.K. El-Naggar, A.K. Singh, T.J. Galloway, D. Raben, D. Wang, C.L. Matthiesen, V. Avizonis, R. Manon, O. Yumen, P.F. Nguyen-Tan, A. Trotti, H.D. Skinner, Q. Zhang, J. Sayre, R.L. Ferris, D. Sidransky, C. Chung




from Cancer via ola Kala on Inoreader http://ift.tt/2hhwC5q
via IFTTT

Shaping the Immune Landscape in Irradiated Breast Cancer Patients with Systemic TGF-β Blockade

alertIcon.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): D. Schaue, M. Xie, J. Ratikan, E. Micewicz, L. Hwang, K. Faull, J. Sayre, P. Lee, J. Glaspy, S. Demaria, S. Formenti, W.H. McBride




from Cancer via ola Kala on Inoreader http://ift.tt/2gSiG4Y
via IFTTT

Predictive Factor Analysis of Response-Adapted Radiation Therapy for Chemotherapy-Sensitive Pediatric Hodgkin Lymphoma: Analysis of the Children's Oncology Group AHOD 0031 Trial

1-s2.0-S0360301616X00144-cov150h.gif

Publication date: 1 December 2016
Source:International Journal of Radiation Oncology*Biology*Physics, Volume 96, Issue 5
Author(s): Anne-Marie Charpentier, Debra L. Friedman, Suzanne Wolden, Cindy Schwartz, Bethany Gill, Jenna Sykes, Alisha Albert-Green, Kara M. Kelly, Louis S. Constine, David C. Hodgson
PurposeTo evaluate whether clinical risk factors could further distinguish children with intermediate-risk Hodgkin lymphoma (HL) with rapid early and complete anatomic response (RER/CR) who benefit significantly from involved-field RT (IFRT) from those who do not, and thereby aid refinement of treatment selection.Methods and MaterialsChildren with intermediate-risk HL treated on the Children's Oncology Group AHOD 0031 trial who achieved RER/CR with 4 cycles of chemotherapy, and who were randomized to 21-Gy IFRT or no additional therapy (n=716) were the subject of this study. Recursive partitioning analysis was used to identify factors associated with clinically and statistically significant improvement in event-free survival (EFS) after randomization to IFRT. Bootstrap sampling was used to evaluate the robustness of the findings.ResultAlthough most RER/CR patients did not benefit significantly from IFRT, those with a combination of anemia and bulky limited-stage disease (n=190) had significantly better 4-year EFS with the addition of IFRT (89.3% vs 77.9% without IFRT; P=.019); this benefit was consistently reproduced in bootstrap analyses and after adjusting for other prognostic factors.ConclusionAlthough most patients achieving RER/CR had favorable outcomes with 4 cycles of chemotherapy alone, those children with initial bulky stage I/II disease and anemia had significantly better EFS with the addition of IFRT as part of combined-modality therapy. Further work evaluating the interaction of clinical and biologic factors and imaging response is needed to further optimize and refine treatment selection.



from Cancer via ola Kala on Inoreader http://ift.tt/2hhpg1T
via IFTTT

Efficacy of three-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus

88x31.png



http://ift.tt/2h5rUvd

Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy in early-stage cervical cancer patients with intermediate risk factors

88x31.png



http://ift.tt/2g9RdHM

History and progression of Fat cadherins in health and disease

88x31.png



http://ift.tt/2h5x6PI

Fluoroscopic Guidance Increases the Incidence of Thoracic Epidural Catheter Placement Within the Epidural Space: A Randomized Trial.

Background and Objectives: Thoracic epidural analgesia can reduce postoperative pain and cardiopulmonary morbidity, but it is associated with a high rate of clinical failure. Up to 50% of clinical failure is thought to be related to technical insertion. In this study, patients undergoing thoracic surgery were randomized to one of two catheter insertion techniques: fluoroscopically guided or conventional loss of resistance with saline/air. Our primary aim was to examine whether fluoroscopic guidance could increase the incidence of correct catheter placement and improve postoperative analgesia. Our secondary aim was to assess the potential impact of correct epidural catheter positioning on length of stay in the postanesthesia care unit and total hospital length of stay. Methods: This randomized clinical trial was conducted at Dartmouth-Hitchcock Medical Center over 25 months (January 2012 to February 2014). Patients (N = 100) undergoing thoracic surgery were randomized to fluoroscopic guidance (n = 47) or to loss of resistance with saline/air (n = 53). Patients were followed for the primary outcomes of 24-hour morphine use, 24-hour numeric pain scores, and the incidence of epidural catheter positioning within the epidural space. Postanesthesia care unit and total hospital lengths of stay were evaluated as secondary outcome measurements and compared for patients with correct epidural catheter positioning and those without correct epidural catheter positioning. Results: One hundred patients were included in an intention-to-treat analysis. Numeric pain scores and 24-hour morphine consumption were no different between groups. Fluoroscopic guidance was associated with an increased incidence of epidural catheter placement within the epidural space compared with loss of resistance with air/saline [fluoroscopic guidance, epidural in 98% (46/47) versus loss of resistance with saline/air, epidural in 74% (39/53)]. There was a significant increase in correct catheter positioning with (odds ratio, 21.07; 95% confidence interval, 2.07-214.38; P = 0.010) or without (odds ratio, 16.15; 95% confidence interval, 2.03-128.47; P = 0.009) adjustment for potentially confounding variables. In an adjusted analysis, correctly positioned thoracic epidural catheters were associated with shorter postanesthesia care unit (5.87 +/- 5.39 hours vs 4.30 +/- 1.171 hours; P = 0.044) and total hospital length of stay (5.77 +/- 4.94 days vs 4.93 +/- 2.79 days; P = 0.031). Conclusions: Fluoroscopic guidance increases the incidence of epidural catheter positioning within the epidural space and may reduce postanesthesia care unit and hospital lengths of stay. Future work should validate the effectiveness of this approach. This clinical trial is registered with ClinicalTrials.gov (NCT02678039). Copyright (C) 2016 by American Society of Regional Anesthesia and Pain Medicine.

http://ift.tt/2g9MkyE

The Neurological Safety of an Epidurally Administered Lipo-PGE1 Agonist in Rats.

Background and Objective: Liposomal prostaglandin E1 (Lipo-PGE1) can inhibit platelet aggregation and vasodilatation and has been found to be therapeutic in ischemia and spinal diseases including stenosis. However, the neurologic safety of epidural administration of lipo-PGE1 requires further study. We investigated the neurotoxicity of epidurally administered lipo-PGE1 agonist in rats. Methods: Twenty-seven rats were randomly divided into three groups: Epidural isotonic sodium chloride solution administration (negative control, group N, n = 9); epidural lipo-PGE1 agonist (group L, n = 9); and epidural alcohol (positive control, group A, n = 9). A single 3-mL injection of lipo-PGE1 agonist (0.3 mL, 0.15 [mu]g/kg), 40% ethanol, or isotonic sodium chloride solution was administered. Neurologic assessments were performed 3, 7, and 21 days after the injection. Histopathologic data were evaluated by one pathologist via light microscopy. Results: All rats in groups N and L, except one rat in group L, demonstrated normal response to neurologic assessments. Histopathologic findings showed no evidence of degenerative myelopathy, chromatolysis, or myelin loss in group N or L at any time point. However, all rats in group A revealed sensory and motor deficits as well as histopathologic abnormalities. Conclusion: Liposomal prostaglandin E1 agonist did not cause any apparent neurologic abnormalities in the spinal cord or dorsal root ganglion, suggesting it is neurologically safe for epidural injection in this species. Additional mammalian study is warranted. Copyright (C) 2016 by American Society of Regional Anesthesia and Pain Medicine.

http://ift.tt/2h5v2qV

A Prospective Randomized Comparative Trial of Targeted Steroid Injection Via Epidural Catheter Versus Standard C7-T1 Interlaminar Approach for the Treatment of Unilateral Cervical Radicular Pain.

Background and Objectives: No study has compared cervical interlaminar epidural steroid injection (CIESI) with epidural catheter advancement to the side and level of pathology versus standard C7-T1 CIESI. This study investigated whether cervical radicular pain is more effectively treated by CIESI with a targeted epidural catheter versus a standard C7-T1 approach. Methods: Prospective, randomized, single-blinded trial. Primary outcome: Numerical Rating Scale (NRS) pain at 1 month. Secondary outcomes: Oswestry Neck Disability Index (ONDI), Pain Disability Index (PDI), McGill Pain Questionnaire (MPQ), Patient Global Impression of Change (PGIC), daily morphine equivalents (DME), and Medication Quantification Scale (MQS) III scores. Results: Seventy-six participants with a median age of 48 years (IQR, 40-56 years), 59% female, with C4 (n = 2), C5 (n = 27), or C6 (n = 47) radicular pain were enrolled. At 1 month in the catheter and no catheter groups, respectively: 26 (72%, 95% confidence interval [CI], 57%-87%) and 23 (60%; 95% CI, 45%-75%) participants reported 50% or greater NRS reduction; 24 (67%; 95% CI, 52%-84%) and 23 (58%; 95% CI, 42%-73%) participants reported 30% or greater ONDI reduction. There were no group differences in median NRS, ONDI, PDI, MPQ, PGIC, DME, or MQSIII scores (P > 0.05). Intergroup differences were not observed at any follow-up interval. Conclusions: This trial showed no significant difference in clinical outcomes with CIESI using a targeted epidural catheter compared to a standard C7-T1 approach for the treatment of unilateral cervical radicular pain at the C5 or C6 level. Both techniques were associated with clinically meaningful improvement across outcome domains of pain, function, disability, and medication use. These effects persisted to 6-month follow-up. The study was registered at Clinical Trials.gov (NCT02095197). Copyright (C) 2016 by American Society of Regional Anesthesia and Pain Medicine.

http://ift.tt/2g9zi49

Anatomic and Ultrasonographic Evaluation of the Knee Sensory Innervation: A Cadaveric Study to Determine Anatomic Targets in the Treatment of Chronic Knee Pain.

Background and Objectives: Osteoarthrosis is a main cause of knee pain in the elderly. Pain associated with this condition is often refractory to conservative treatment. Total knee replacement may be the best option for severe pathologies; however, the occurrence of a chronic pain state after knee replacement has been well documented in the literature. The previous descriptions of the genicular nerves have been considered somewhat inaccurate. This innervation is complex and exhibits significant interindividual variability. A precise description of these nerves will increase our knowledge on different patterns and targets, to guide treatment and improve outcomes. The objective of this study was to determine sensory innervation patterns of the knee joint and correlate them with dynamic visualization via ultrasound imaging. Methods: Systematic cadaveric dissections were performed to determine different patterns of sensory innervation of the knee followed by ultrasonographic correlation. A short-axis ultrasound view of the nerves was used to inject India ink at several points along their course to facilitate the anatomic dissection and confirm their location among adjacent structures. Results: The visualized structures were the following: infrapatellar branch of the saphenous nerve, the branches to vastus medialis, intermedius, and lateralis muscles; obturator nerve; and lateral retinacular and recurrent peroneal nerves. Conclusions: We conclude that reproducible correlations showing the sensory innervations for the knee are linked to muscular structures. However, high variability among individuals makes it difficult to predict their paths. Our systematic approach, using direct visualization via ultrasound, allows a more accurate placement of the needle for therapeutic purposes. Copyright (C) 2016 by American Society of Regional Anesthesia and Pain Medicine.

http://ift.tt/2gS9KN1

Lung regeneration: steps toward clinical implementation and use.

wk-health-logo.gif

Purpose of review: Whole lung tissue engineering is a relatively new area of investigation. In a short time, however, the field has advanced quickly beyond proof of concept studies in rodents and now stands on the cusp of wide-spread scale up to large animal studies. Therefore, this technology is ever closer to being directly clinically relevant. Recent findings: The main themes in the literature include refinement of the fundamental components of whole lung engineering and increasing effort to direct induced pluripotent stem cells and lung progenitor cells toward use in lung regeneration. There is also increasing need for and emphasis on functional evaluation in the lab and in vivo, and the use of all of these tools to construct and evaluate forthcoming clinically scaled engineered lung. Summary: Ultimately, the goal of the research described herein is to create a useful clinical product. In the intermediate time, however, the tools described here may be employed to advance our knowledge of lung biology and the organ-specific regenerative capacity of lung stem and progenitor cells. Copyright (C) 2016 YEAR Wolters Kluwer Health, Inc. All rights reserved.

http://ift.tt/2h1Fyg1